C
angiotensin-converting enzyme (ACE) level
Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
13
evidence score
Also known as: angiotensin converting enzyme
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 3meta-analyses: 0trials: 10.4genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Atherosclerotic Vessel Changes in Sarcoidosis. — Advances in experimental medicine and biology 2016 · PMID 26820732
Clinical trials (10)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT06562582 | STunning in Acute Myocardial Infarction - Beta Blockers, Angiotensin Converting Enzyme Inhibitors and Sodium/Glucose Cotransporter 2 Inhibitors Trial A Low Intervention Clinical Tria | RECRUITING | INTERVENTIONAL | Bisoprolol Oral Tablet, Ramipril Oral Product, Dapagliflozin Oral Product |
| NCT04477590 | Optimizing Exercise Training Effects on Metabolic Syndrome Factors by Altering the Timing of Medication and Meal Ingestion | UNKNOWN | INTERVENTIONAL | EXERCISE TRAINING WITH OR WITHOUT MEDICATION |
| NCT03686696 | Randomized Evaluation of Beta Blocker and Angiotensin Converting Enzyme Inhibitor (ACEI) /Angiotensin Receptor Blocker (ARB) Treatment in MINOCA Patients. | TERMINATED | INTERVENTIONAL | Beta blocker, ACEI, ARB |
| NCT03640221 | A Double-blind, Randomized, Parallel 2- Arm Study to Compare the Efficacy of Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes Who Are Receiving Background Standard-of-care Cardio-metabolic Therapy With Metformin, an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker, and a Statin. | WITHDRAWN | INTERVENTIONAL | Ertugliflozin, Hydrochlorothiazide 12.5mg, Microneurography |
| NCT02008786 | The Effects of Statin and Angiotensin-converting Enzyme Inhibitor on Coronary Flow Reserve, indEx of Microcirculatory Resistance, and Symptoms in Patients With Spontaneous Coronary Artery Dissection (SAFER-SCAD) Study | TERMINATED | INTERVENTIONAL | ramipril, rosuvastatin, placebo |
| NCT01118520 | An Evaluation of the Effect of an Angiotensin-converting Enzyme (ACE) Inhibitor on the Growth Rate of Small Abdominal Aortic Aneurysms. | COMPLETED | INTERVENTIONAL | perindopril arginine, amlodipine 5mgs, placebo |
| NCT01037530 | A Double Blind, Randomised, Placebo Controlled Trial to Study the Clinical and Cost Effectiveness of the Angiotensin Converting Enzyme Inhibitor, Ramipril, in Intermittent Claudicants | COMPLETED | INTERVENTIONAL | Ramipril |
| NCT01195662 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication | COMPLETED | INTERVENTIONAL | Dapagliflozin, Placebo matching Dapagliflozin |
| NCT00005928 | Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance | COMPLETED | INTERVENTIONAL | Ramipril |
| NCT04334824 | Use of Hydrochlorothiazide and the Risk of Skin Cancer | COMPLETED | OBSERVATIONAL | Hydrochlorothiazide, Angiotensin-converting enzyme (ACE) inhibitors |
Genetic associations (0)
None linked.